NKGN – nkgen biotech, inc. (US:NASDAQ)
Stock Stats
News
NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinson’s Disease
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
Form 4 NKGen Biotech, Inc. For: Feb 12 Filed by: Scott Kathleen D.
Form 4 NKGen Biotech, Inc. For: Feb 12 Filed by: Kim Yong Man
Form 4 NKGen Biotech, Inc. For: Feb 12 Filed by: Song Paul Y.
Form 4 NKGen Biotech, Inc. For: Feb 12 Filed by: Gagnon Pierre
Form 4 NKGen Biotech, Inc. For: Feb 12 Filed by: Klowden Michael
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.